Annual CAPEX
$15.00 M
+$14.55 M+3233.33%
31 December 2023
Summary:
Rigel Pharmaceuticals annual capital expenditures is currently $15.00 million, with the most recent change of +$14.55 million (+3233.33%) on 31 December 2023. During the last 3 years, it has risen by +$13.74 million (+1088.59%). RIGL annual CAPEX is now at all-time high.RIGL CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$10.00 K
-$212.00 K-95.50%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly capital expenditures is currently $10.00 thousand, with the most recent change of -$212.00 thousand (-95.50%) on 30 September 2024. Over the past year, it has increased by +$10.00 thousand (+100.00%). RIGL quarterly CAPEX is now -99.93% below its all-time high of $15.00 million, reached on 31 March 2023.RIGL Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$370.00 K
+$10.00 K+2.78%
30 September 2024
Summary:
Rigel Pharmaceuticals TTM capital expenditures is currently $370.00 thousand, with the most recent change of +$10.00 thousand (+2.78%) on 30 September 2024. Over the past year, it has dropped by -$14.70 million (-97.55%). RIGL TTM CAPEX is now -97.58% below its all-time high of $15.26 million, reached on 30 June 2023.RIGL TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3233.3% | +100.0% | -97.5% |
| 3 y3 years | +1088.6% | -94.1% | -67.9% |
| 5 y5 years | +1256.2% | -97.2% | -59.5% |
RIGL CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +3233.3% | -99.9% | +127.8% | -97.6% | +168.1% |
| 5 y | 5 years | at high | +3233.3% | -99.9% | +122.7% | -97.6% | +168.1% |
| alltime | all time | at high | >+9999.0% | -99.9% | +100.2% | -97.6% | +107.1% |
Rigel Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $10.00 K(-95.5%) | $370.00 K(+2.8%) |
| June 2024 | - | $222.00 K(+60.9%) | $360.00 K(+160.9%) |
| Mar 2024 | - | $138.00 K(>+9900.0%) | $138.00 K(-99.1%) |
| Dec 2023 | $15.00 M(+3233.3%) | $0.00(0.0%) | $15.00 M(-0.5%) |
| Sept 2023 | - | $0.00(0.0%) | $15.07 M(-1.2%) |
| June 2023 | - | $0.00(-100.0%) | $15.26 M(+0.2%) |
| Mar 2023 | - | $15.00 M(>+9900.0%) | $15.23 M(+3283.6%) |
| Dec 2022 | $450.00 K(-28.2%) | $73.00 K(-61.4%) | $450.00 K(+26.4%) |
| Sept 2022 | - | $189.00 K(-625.0%) | $356.00 K(+5.6%) |
| June 2022 | - | -$36.00 K(-116.1%) | $337.00 K(-56.8%) |
| Mar 2022 | - | $224.00 K(-1166.7%) | $780.00 K(+24.4%) |
| Dec 2021 | $627.00 K(-50.3%) | -$21.00 K(-112.4%) | $627.00 K(-45.6%) |
| Sept 2021 | - | $170.00 K(-58.2%) | $1.15 M(-2.1%) |
| June 2021 | - | $407.00 K(+473.2%) | $1.18 M(+62.1%) |
| Mar 2021 | - | $71.00 K(-85.9%) | $726.00 K(-42.5%) |
| Dec 2020 | $1.26 M(-13.3%) | $504.00 K(+158.5%) | $1.26 M(-7.8%) |
| Sept 2020 | - | $195.00 K(-543.2%) | $1.37 M(-10.3%) |
| June 2020 | - | -$44.00 K(-107.2%) | $1.53 M(-9.4%) |
| Mar 2020 | - | $607.00 K(-0.7%) | $1.69 M(+15.8%) |
| Dec 2019 | $1.46 M(+31.6%) | $611.00 K(+73.6%) | $1.46 M(+59.4%) |
| Sept 2019 | - | $352.00 K(+206.1%) | $913.00 K(+27.3%) |
| June 2019 | - | $115.00 K(-69.5%) | $717.00 K(-44.2%) |
| Mar 2019 | - | $377.00 K(+446.4%) | $1.29 M(+16.3%) |
| Dec 2018 | $1.11 M(+574.4%) | $69.00 K(-55.8%) | $1.11 M(+1.5%) |
| Sept 2018 | - | $156.00 K(-77.2%) | $1.09 M(+10.1%) |
| June 2018 | - | $684.00 K(+247.2%) | $990.00 K(+209.4%) |
| Mar 2018 | - | $197.00 K(+271.7%) | $320.00 K(+95.1%) |
| Dec 2017 | $164.00 K(-79.6%) | $53.00 K(-5.4%) | $164.00 K(+40.2%) |
| Sept 2017 | - | $56.00 K(+300.0%) | $117.00 K(-62.6%) |
| June 2017 | - | $14.00 K(-65.9%) | $313.00 K(-40.3%) |
| Mar 2017 | - | $41.00 K(+583.3%) | $524.00 K(-34.8%) |
| Dec 2016 | $804.00 K(+47.3%) | $6000.00(-97.6%) | $804.00 K(-13.7%) |
| Sept 2016 | - | $252.00 K(+12.0%) | $932.00 K(-5.6%) |
| June 2016 | - | $225.00 K(-29.9%) | $987.00 K(+18.2%) |
| Mar 2016 | - | $321.00 K(+139.6%) | $835.00 K(+52.9%) |
| Dec 2015 | $546.00 K(+32.2%) | $134.00 K(-56.4%) | $546.00 K(-10.8%) |
| Sept 2015 | - | $307.00 K(+320.5%) | $612.00 K(+130.9%) |
| June 2015 | - | $73.00 K(+128.1%) | $265.00 K(-0.7%) |
| Mar 2015 | - | $32.00 K(-84.0%) | $267.00 K(-35.4%) |
| Dec 2014 | $413.00 K(-66.2%) | $200.00 K(-600.0%) | $413.00 K(+8.4%) |
| Sept 2014 | - | -$40.00 K(-153.3%) | $381.00 K(-30.6%) |
| June 2014 | - | $75.00 K(-57.9%) | $549.00 K(-24.1%) |
| Mar 2014 | - | $178.00 K(+6.0%) | $723.00 K(-40.8%) |
| Dec 2013 | $1.22 M(-63.8%) | $168.00 K(+31.3%) | $1.22 M(-26.2%) |
| Sept 2013 | - | $128.00 K(-48.6%) | $1.65 M(-13.4%) |
| June 2013 | - | $249.00 K(-63.2%) | $1.91 M(-23.0%) |
| Mar 2013 | - | $676.00 K(+12.5%) | $2.48 M(-26.6%) |
| Dec 2012 | $3.38 M | $601.00 K(+56.5%) | $3.38 M(+14.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | $384.00 K(-53.1%) | $2.96 M(-5.6%) |
| June 2012 | - | $818.00 K(-48.0%) | $3.14 M(+4.0%) |
| Mar 2012 | - | $1.57 M(+750.8%) | $3.02 M(+31.0%) |
| Dec 2011 | $2.30 M(-35.3%) | $185.00 K(-67.0%) | $2.30 M(-24.4%) |
| Sept 2011 | - | $561.00 K(-19.5%) | $3.05 M(-9.9%) |
| June 2011 | - | $697.00 K(-19.0%) | $3.38 M(-15.0%) |
| Mar 2011 | - | $860.00 K(-7.3%) | $3.98 M(+11.8%) |
| Dec 2010 | $3.56 M(+2424.8%) | $928.00 K(+3.5%) | $3.56 M(+32.9%) |
| Sept 2010 | - | $897.00 K(-30.7%) | $2.68 M(+48.4%) |
| June 2010 | - | $1.29 M(+194.3%) | $1.80 M(+216.7%) |
| Mar 2010 | - | $440.00 K(+856.5%) | $570.00 K(+304.3%) |
| Dec 2009 | $141.00 K(-94.4%) | $46.00 K(+91.7%) | $141.00 K(-83.3%) |
| Sept 2009 | - | $24.00 K(-60.0%) | $843.00 K(-37.4%) |
| June 2009 | - | $60.00 K(+445.5%) | $1.35 M(-39.4%) |
| Mar 2009 | - | $11.00 K(-98.5%) | $2.22 M(-11.4%) |
| Dec 2008 | $2.51 M(+168.7%) | $748.00 K(+41.7%) | $2.51 M(+37.1%) |
| Sept 2008 | - | $528.00 K(-43.5%) | $1.83 M(+20.3%) |
| June 2008 | - | $934.00 K(+214.5%) | $1.52 M(+96.0%) |
| Mar 2008 | - | $297.00 K(+330.4%) | $775.00 K(-16.9%) |
| Dec 2007 | $933.00 K(+2.2%) | $69.00 K(-68.5%) | $933.00 K(-13.8%) |
| Sept 2007 | - | $219.00 K(+15.3%) | $1.08 M(+11.2%) |
| June 2007 | - | $190.00 K(-58.2%) | $973.00 K(-4.0%) |
| Mar 2007 | - | $455.00 K(+108.7%) | $1.01 M(+11.1%) |
| Dec 2006 | $913.00 K(-49.1%) | $218.00 K(+98.2%) | $913.00 K(-53.3%) |
| Sept 2006 | - | $110.00 K(-52.4%) | $1.96 M(+7.2%) |
| June 2006 | - | $231.00 K(-34.7%) | $1.82 M(+9.3%) |
| Mar 2006 | - | $354.00 K(-71.9%) | $1.67 M(-6.9%) |
| Dec 2005 | $1.79 M(+16.1%) | $1.26 M(-6104.8%) | $1.79 M(+46.4%) |
| Sept 2005 | - | -$21.00 K(-127.6%) | $1.23 M(-33.4%) |
| June 2005 | - | $76.00 K(-84.1%) | $1.84 M(-6.4%) |
| Mar 2005 | - | $478.00 K(-30.9%) | $1.97 M(+27.2%) |
| Dec 2004 | $1.54 M(+24.4%) | $692.00 K(+16.7%) | $1.54 M(+46.3%) |
| Sept 2004 | - | $593.00 K(+193.6%) | $1.06 M(+103.9%) |
| June 2004 | - | $202.00 K(+248.3%) | $518.00 K(-30.4%) |
| Mar 2004 | - | $58.00 K(-71.4%) | $744.00 K(-40.1%) |
| Dec 2003 | $1.24 M(-24.0%) | $203.00 K(+269.1%) | $1.24 M(-123.8%) |
| Sept 2003 | - | $55.00 K(-87.1%) | -$5.22 M(+469.4%) |
| June 2003 | - | $428.00 K(-23.0%) | -$917.00 K(-292.6%) |
| Mar 2003 | - | $556.00 K(-108.9%) | $476.00 K(-70.9%) |
| Dec 2002 | $1.64 M(-49.4%) | -$6.26 M(-243.6%) | $1.64 M(-80.8%) |
| Sept 2002 | - | $4.36 M(+139.4%) | $8.50 M(+76.7%) |
| June 2002 | - | $1.82 M(+6.2%) | $4.81 M(+32.6%) |
| Mar 2002 | - | $1.72 M(+183.0%) | $3.63 M(+12.4%) |
| Dec 2001 | $3.23 M(-10.7%) | $606.00 K(-9.6%) | $3.23 M(+23.1%) |
| Sept 2001 | - | $670.00 K(+5.0%) | $2.62 M(+34.3%) |
| June 2001 | - | $638.00 K(-51.5%) | $1.95 M(+48.5%) |
| Mar 2001 | - | $1.31 M | $1.31 M |
| Dec 2000 | $3.62 M(-49.0%) | - | - |
| Dec 1999 | $7.09 M | - | - |
FAQ
- What is Rigel Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual CAPEX year-on-year change?
- What is Rigel Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Rigel Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals TTM CAPEX year-on-year change?
What is Rigel Pharmaceuticals annual capital expenditures?
The current annual CAPEX of RIGL is $15.00 M
What is the all time high annual CAPEX for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual capital expenditures is $15.00 M
What is Rigel Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, RIGL annual capital expenditures has changed by +$14.55 M (+3233.33%)
What is Rigel Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of RIGL is $10.00 K
What is the all time high quarterly CAPEX for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly capital expenditures is $15.00 M
What is Rigel Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, RIGL quarterly capital expenditures has changed by +$10.00 K (+100.00%)
What is Rigel Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of RIGL is $370.00 K
What is the all time high TTM CAPEX for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high TTM capital expenditures is $15.26 M
What is Rigel Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, RIGL TTM capital expenditures has changed by -$14.70 M (-97.55%)